A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Clinical trial NCT02659020 · COMPLETED
Trial details
- NCT number
- NCT02659020
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-07-28
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.